Cofco Biotechnology (000930.SZ) released its semi-annual report for the year 2024, with revenue of 9.911 billion yuan for the reporting period, a year-on-year increase of 6.45%; net income attributable to shareholders of listed companies was 61.4817 million yuan, turning loss into profit compared to the same period last year; net income attributable to shareholders of listed companies after deducting non-recurring gains and losses was 18.6054 million yuan; basic earnings per share was 0.0331 yuan.
中粮科技(000930.SZ)：上半年净利润6148.17万元 同比扭亏
COFCO Biotechnology (000930.SZ): The net income in the first half of the year was 61.4817 million yuan, turning losses year-on-year.
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
Hot News
Updated